2017 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Neurosciences
Katharina Domschke mainly investigates Panic disorder, Neuroscience, Anxiety, Internal medicine and Amygdala. Her Panic disorder research integrates issues from Genetics, Anxiety disorder, Allele, Panic and Monoamine oxidase A. The various areas that Katharina Domschke examines in her Neuroscience study include Inflammation, Interleukin 6 and Neurotrophic factors.
The Anxiety study combines topics in areas such as Neuroimaging and Clinical psychology. Her biological study spans a wide range of topics, including Antidepressant, Endocrinology, Single-nucleotide polymorphism and Oncology. Katharina Domschke combines subjects such as Serotonin transporter and DNA methylation with her study of Endocrinology.
Her scientific interests lie mostly in Anxiety, Internal medicine, Panic disorder, Clinical psychology and Neuroscience. Anxiety is a subfield of Psychiatry that Katharina Domschke studies. Her research integrates issues of Antidepressant, Endocrinology, Depression, Oncology and Single-nucleotide polymorphism in her study of Internal medicine.
Her Single-nucleotide polymorphism research includes themes of Schizophrenia and Candidate gene. Her Panic disorder research includes elements of Genetics, Anxiety disorder, Panic and Monoamine oxidase A. The study incorporates disciplines such as Neuropeptide S and Neuropeptide S receptor in addition to Neuroscience.
Her primary scientific interests are in Internal medicine, Anxiety, Clinical psychology, DNA methylation and Depression. Katharina Domschke has researched Internal medicine in several fields, including Gastroenterology, Major depressive disorder, Endocrinology and Oncology. Her Anxiety research is multidisciplinary, incorporating perspectives in Arousal, Single-nucleotide polymorphism and Comorbidity.
Her work on Stressor as part of general Clinical psychology study is frequently connected to Variation, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Her DNA methylation research is multidisciplinary, relying on both Serotonin transporter, Methylation, Epigenetics and Oxytocin receptor. Her Serotonin transporter research incorporates themes from Panic disorder and Bioinformatics.
The scientist’s investigation covers issues in DNA methylation, Internal medicine, Epigenetics, Autoantibody and Serotonin transporter. Her DNA methylation study integrates concerns from other disciplines, such as Neuroscience and Oxytocin receptor. Her work deals with themes such as Major depressive disorder, Endocrinology, Methylation and CpG site, which intersect with Internal medicine.
Her work carried out in the field of Epigenetics brings together such families of science as Psychological resilience and Anxiety. Her work in the fields of Anxiety, such as Anxiety disorder, overlaps with other areas such as CTQ tree. She works mostly in the field of Serotonin transporter, limiting it down to topics relating to Clinical psychology and, in certain cases, Temperament, Genetic modulation, Panic disorder and Affective temperaments.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
Naomi R. Wray;Stephan Ripke;Stephan Ripke;Stephan Ripke;Manuel Mattheisen;MacIej Trzaskowski.
Nature Genetics (2018)
Limbic Scars: Long-Term Consequences of Childhood Maltreatment Revealed by Functional and Structural Magnetic Resonance Imaging
Udo Dannlowski;Anja Stuhrmann;Victoria Beutelmann;Peter Zwanzger.
Biological Psychiatry (2012)
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
C. Hiemke;N. Bergemann;H. W. Clement;A. Conca.
Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions
David M. Howard;Mark J. Adams;Toni Kim Clarke;Jonathan D. Hafferty.
Nature Neuroscience (2019)
Interoceptive sensitivity in anxiety and anxiety disorders: an overview and integration of neurobiological findings.
Katharina Domschke;Stephan Stevens;Bettina Pfleiderer;Alexander L. Gerlach.
Clinical Psychology Review (2010)
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo
P.F. Sullivan;E.J.C. de Geus;G. Willemsen;M.R. James.
Molecular Psychiatry (2009)
A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression
Marcus Ising;Susanne Lucae;Elisabeth B. Binder;Thomas Bettecken.
Archives of General Psychiatry (2009)
Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders
Phil H. Lee;Verneri Anttila;Hyejung Won;Yen-Chen A. Feng.
Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity.
Udo Dannlowski;Patricia Ohrmann;Carsten Konrad;Katharina Domschke.
The International Journal of Neuropsychopharmacology (2009)
Association of the functional V158M catechol- O -methyl-transferase polymorphism with panic disorder in women
Katharina Domschke;Christine M. Freitag;Gregor Kuhlenbäumer;Anja Schirmacher.
The International Journal of Neuropsychopharmacology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: